Oncology Resource Group’s experts provide best-in-class competitive intelligence to commercial, medical and scientific teams worldwide.
By empowering talented scientists that intensely focus on oncology drug markets, and working hand-in-hand with clients to develop the most relevant forward-looking resources possible, we achieve new standards of analytical excellence and deliver the most accurate, insightful, and robust market planning resources available.
We are committed to helping our clients succeed in creating winning strategies and making the right business decisions for their new products, brands, franchises, partnerships, and alliances.
Through rigorous and sophisticated methodologies, our firm interprets numerous scientific, clinical, and therapy area developments on an ongoing basis and is adept at evaluating the commercial impact of complicated interconnected market events and how changes in treatment trends, patient populations, and risk factors will weigh into the future marketplace. Our fundamental belief is that clients are best served by our team’s full-time, exclusive study of oncology markets which enable the production of market planning resources that contain more depth, insight, and precision than would otherwise be possible.